New hope for leukemia patients? early trial of karonudib begins

NCT ID NCT04077307

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 23 times

Summary

This early-stage study tests a new drug called Karonudib in 9 adults with blood cancers like leukemia who have run out of standard treatments. The main goal is to check if the drug is safe and tolerable, and to find the right dose for future studies. Researchers will also look for any signs that the drug helps control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Aarhus University Hospital

    RECRUITING

    Aarhus, Denmark

    Contact

  • Karolinska University Hospital

    RECRUITING

    Huddinge, Sweden

    Contact

    Contact

  • Rigshospitalet Copenhagen University Hospital

    RECRUITING

    Copenhagen, Denmark

    Contact

  • University Clinical Center Belgrade

    RECRUITING

    Belgrade, Serbia

    Contact

  • University Clinical Center Kragujevac

    RECRUITING

    Kragujevac, Serbia

    Contact

  • Örebro University Hospital

    RECRUITING

    Örebro, Sweden

    Contact

Conditions

Explore the condition pages connected to this study.